Skip to content

Testing of safety and effectiveness of Under eye serum and anti aging under eye serum

A study to evaluate the Opthalmologic and Dermatologic safety of the Under Eye Serums by Repeat Use Test (7 days) in Healthy Subjects with Equal Representation of Different Skin Types. - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2018/03/012305
Enrollment
70
Registered
2018-03-05
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: 1) Under eye serum 2) Antiaging under eye serum: Dose: One drop is to be dispensed on the fingertip and gently massaged over the under eye area and lateral canthus /crows-feet/ outer co

Sponsors

ITC Life Sciences Technology Centre
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Subjects in generally good health. 2.Subjects willing to abide by the study requirements and protocol. Special criteria: 3.Equal representation of subjects with visible Finelines and / or Wrinkles, Under Eye Puffiness and Under eye dark circles in both groups 4.Atleast 18 Subjects with visible Finelines and / or Wrinkles 5.Atleast 18 Subjects with Under Eye Puffiness 6.Atleast 18 Subjects with Under Eye Dark circles 7.Equal representation of different skin types- Normal, Oily, Dry and Combination Sensitive. 8.Subjects of varied eye conditions such as normal condition, sensitive condition and contact lens users

Exclusion criteria

Exclusion criteria: 1.Women subjects who are pregnant or lactating 2.A known history or present condition of allergic response to any cosmetic products (eye/ facial cosmetic products). 3.Subjects having eye infection or allergy. 4.Subjects having extremely sensitive eye condition. 5.Subjects having any form cutaneous disease which may influence the study result.

Design outcomes

Primary

MeasureTime frame
To evaluate the Ophthalmologic and Dermal safety of the test products in causing no ocular irritation or dermal irritation on repeated use of test products involving subjects of varied eye conditions such as normal condition, sensitive condition and contact lens users.To evaluate the product sensorials and post use skin sensorials and efficacy during one week use.Timepoint: Approximately 1 week for each subject

Secondary

MeasureTime frame
NilTimepoint: Nil

Countries

India

Contacts

Public ContactRitambhara

MS Clinical Research Pvt Ltd

sapna.r@mscr.in918040917253

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026